On September 12, 2022 Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, reported that Dror Bashan, the Company’s President and Chief Executive Officer, will present in person on Wednesday, September 14, 2022 at 11:00 a.m. Eastern Daylight Time (EDT) at the H.C. Wainwright 24th Annual Global Investment Conference, a hybrid conference (Press release, Protalix, SEP 12, 2022, https://www.prnewswire.com/news-releases/protalix-biotherapeutics-to-present-in-person-at-the-hc-wainwright-24th-annual-global-investment-conference-301622194.html [SID1234619467]). The conference is being held on September 12-14, 2022 at the Lotte New York Palace Hotel in New York City. Virtual participation will also be available.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mr. Bashan will provide a live corporate overview at the conference, a webcast of which will be available on–line. The live presentation replaces the pre-recorded presentation announced by the Company on September 6, 2022.
Live Presentation and Webcast Details:
Wednesday, September 14, 2022 at 11:00 a.m. Eastern Daylight Time (EDT) in the Adams Room.
Company Link: View Source
Webcast Link: View Source
The live presentation webcast and the pre-recorded webcast will both be available for replay for at least two weeks on the Events Calendar of the Investors section of the Company’s website, at the above link.
The Company’s management will participate in one-on-one meetings with investors who are registered to attend the conference. If you are an institutional investor and would like to attend the Company’s presentation, registration for the conference is available at View Source Once your registration is confirmed, you will be prompted to log onto the conference website to request a one-on-one meeting with the Company.